GLP-1 Weight Loss Drugs Face Stigma Despite Clinical Benefits
GLP-1 drugs, such as Ozempic, have been heralded as a breakthrough in treating obesity, yet they face significant stigma. Despite their clinical potential, users of these drugs often encounter judgment and shaming, both socially and in healthcare settings. Research indicates that people perceive those who lose weight using GLP-1s more negatively than those who lose weight through traditional methods or not at all. This stigma is rooted in cultural beliefs about weight and personal responsibility, viewing the use of such drugs as a 'shortcut'. The social media communities around GLP-1s are filled with stories of users facing criticism from partners, coworkers, and even healthcare professionals. 
